BioLife Solutions, Inc. Debt Securities, Available-for-sale, Noncurrent
BioLife Solutions, Inc. (BLFS) had Debt Securities, Available-for-sale, Noncurrent of $4.88 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2024-11-12
- 2024-09-30: Debt Securities, Available-for-sale, Noncurrent $4.88M.
- 2024-06-30: Debt Securities, Available-for-sale, Noncurrent $2.69M.
- 2024-03-31: Debt Securities, Available-for-sale, Noncurrent $822.00K.
- 2023-12-31: Debt Securities, Available-for-sale, Noncurrent $548.00K.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2024-09-30 | $4.88M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.69M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $822.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $548.00K 10-K · filed 2024-02-29 |
| 2023-09-30 | $1.16M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.84M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.02M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.33M 10-K · filed 2023-03-31 |
| 2022-09-30 | $490.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $489.00K 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |